Home pageInternational cooperationUK-based pharmaceutical SME seeks novel early stage...

UK-based pharmaceutical SME seeks novel early stage molecules in the immuno-oncology space

Date: 9.12.2016 

 

Summary:

A UK-based pharmaceutical SME s looking for novel small molecules with immune-oncology activity especially in regard to difficult to treat cancers. The SME will further develop these novel compounds to improve their efficacy and safety profiles with a view to licensing the improved molecules to larger pharmaceutical companies to take onto the market. The SME seeks to partner with universities, research Institutes and SMEs in the form of a licensing agreement or technical cooperation agreement.

Reference:

TRUK20161011001

Country:

United Kingdom

Submitted:

December 09 2016

Updated:

December 09 2016

 

View Partnering Opportunity

 

KEYWORDS

Market:

In vitro Testing, Trials, Molecular design, Pharmaceuticals/fine chemicals

Technology:

Cytology, Cancerology, Oncology, Medical Research, Pharmaceutical Products / Drugs

NACE:

Manufacture of pharmaceutical preparations, Research and experimental development on biotechnology, Other research and experimental development on natural sciences and engineering 

   


Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.

 

 


 

OPPI, MPO, EU

We Recommend

Cayman

CEBIO

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

LinkedIn
TOPlist